头颈部微血管游离组织移植术后住院期间手术并发症
该回顾性研究纳入1090例因原发或复发性头颈癌行微血管游离组织移植(MFTT)重建的患者,其中126例(11.6%)发生住院期间并发症。手术部位血肿发生最早(中位术后第1天),供区感染最晚(中位术后第11.5天);不同皮瓣类型之间并发症发生时间无显著差异(p>0.05)。
要点
- 1090例MFTT重建患者中126例(11.6%)发生住院并发症,涉及腓骨、股前外侧、桡前臂皮瓣。
- 手术部位血肿发生最早(中位术后第1天),供区感染最晚(中位术后第11.5天)。
- 血肿和皮瓣失败在住院早期出现,裂开、感染和瘘出现较晚;不同皮瓣类型间并发症时间无显著差异。
核心结论
- 血肿形成和皮瓣失败在住院期间发生最早,而裂开、感染和瘘发生较晚。
- 不同皮瓣类型之间并发症发生时间无差异。
研究设计与样本
- 回顾性研究,纳入某三级医疗机构因原发或复发性头颈癌行MFTT重建且发生住院术后并发症的患者。
- 共1090例患者行MFTT重建,其中126例(11.6%)发生住院并发症,包括腓骨皮瓣35例、股前外侧皮瓣60例、桡前臂皮瓣31例。
- 采用Kruskal-Wallis检验比较不同皮瓣类型间并发症中位术后天数(POD)起病时间。
主要发现
- 手术部位血肿的POD起病时间最短(中位数=1,IQR 1-5)。
- 供区感染的POD起病时间最长(中位数=11.5,IQR 8-15)。
- 不同皮瓣类型与并发症POD起病时间之间无显著差异(p>0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Complications following head and neck microvascular free tissue transfer (MFTT) are common. Less is known about when they occur. METHOD: Retrospective study of patients with primary or recurrent head and neck cancer undergoing MFTT reconstruction at a tertiary care institution. MFTT reconstructions with inpatient postoperative complications were included. The Kruskal-Wallis test was used to compare median postoperative day (POD) onset of complication by flap type. RESULTS: Of 1090 patients undergoing MFTT reconstruction, 126 (11.6%) patients experienced inpatient complications including fibula (n = 35), anterolateral thigh (n = 60), or radial forearm (n = 31) MFTTs. POD onset was shortest for surgical site hematoma (median = 1 [IQR 1-5]), and longest for donor site infection (median = 11.5 [IQR 8-15]). There was no significant difference between flap types and POD onset of complications (p > 0.05). CONCLUSION: Hematoma formation and flap failure occur earliest during hospitalization, while dehiscence, infection, and fistula occur later. There is no difference in complication timing between flap types.
引用
- Abdulbaki H, Ha PK, Knott PD, et al. Postoperative inpatient surgical complications following head and neck microvascular free tissue transfer. Head Neck. 2024. PMID: 38445792. doi:10.1002/hed.27728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。